Finally, our results demonstrated that RAD51AP1 silencing significantly inhibited cell proliferation and invasion in ESCC, thereby highlighting its potential as a novel target for ESCC treatment. This evidence concerns the gene RAD51AP1 and esophageal squamous cell carcinoma.